Nurix Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK, INC. | 05/13/2026 | 8.93 M | $138.35 M | 0.57% | 8.11% |
| REDMILE GROUP, LLC | 05/15/2026 | 7.73 M | $119.86 M | -4.46% | 7.03% |
| VESTAL POINT CAPITAL, LP | 05/15/2026 | 6.50 M | $100.75 M | 38.59% | 5.91% |
| DEEP TRACK CAPITAL, LP | 05/15/2026 | 6.35 M | $98.35 M | -9.82% | 5.76% |
| FMR LLC | 05/15/2026 | 5.54 M | $85.89 M | 30.87% | 5.03% |
| STATE STREET CORP | 05/15/2026 | 5.14 M | $79.69 M | 44.44% | 4.67% |
| MORGAN STANLEY | 05/15/2026 | 4.93 M | $76.45 M | 1.04% | 4.48% |
| BAKER BROS. ADVISORS LP | 05/15/2026 | 4.66 M | $72.21 M | 0.00% | 4.23% |
| 05/15/2026 | 4.43 M | $68.62 M | 100.00% | 4.02% | |
| GENERAL ATLANTIC, L.P. | 05/15/2026 | 4.10 M | $63.58 M | -16.24% | 3.73% |
| PERCEPTIVE ADVISORS LLC | 05/29/2026 | 3.71 M | $57.52 M | 4.36% | 3.37% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 05/15/2026 | 3.29 M | $51.00 M | 1.29% | 2.99% |
| PICTET ASSET MANAGEMENT HOLDING SA | 04/22/2026 | 2.73 M | $42.26 M | -21.38% | 2.48% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 2.52 M | $39.07 M | 5.67% | 2.29% |
| RUBRIC CAPITAL MANAGEMENT LP | 05/15/2026 | 2.47 M | $38.35 M | 0.00% | 2.25% |
| DEUTSCHE BANK AG\ | 05/06/2026 | 2.30 M | $35.57 M | -7.71% | 2.09% |
| COMMODORE CAPITAL LP | 05/15/2026 | 2.28 M | $35.26 M | 0.00% | 2.07% |
| BRAIDWELL LP | 05/15/2026 | 1.75 M | $27.14 M | -19.83% | 1.59% |
| 05/15/2026 | 1.74 M | $27.02 M | 0.00% | 1.58% | |
| ARK INVESTMENT MANAGEMENT LLC | 05/12/2026 | 1.72 M | $26.68 M | 7.40% | 1.56% |
| LONGAEVA PARTNERS L.P. | 05/15/2026 | 1.49 M | $23.10 M | 60.63% | 1.35% |
| CITADEL ADVISORS LLC | 05/15/2026 | 1.34 M | $20.83 M | 16.55% | 1.22% |
| GOLDMAN SACHS GROUP INC | 05/15/2026 | 1.32 M | $20.44 M | 22.37% | 1.20% |
| EVENTIDE ASSET MANAGEMENT, LLC | 05/15/2026 | 1.30 M | $20.12 M | 0.00% | 1.18% |
| KYNAM CAPITAL MANAGEMENT, LP | 05/15/2026 | 1.19 M | $18.52 M | -39.36% | 1.09% |
| SUMITOMO MITSUI TRUST HOLDINGS, INC. | 04/30/2026 | 1.18 M | $18.31 M | -8.48% | 1.07% |
| NIKKO ASSET MANAGEMENT AMERICAS, INC. | 05/07/2026 | 1.18 M | $18.28 M | -8.48% | 1.07% |
| 05/08/2026 | 1.10 M | $17.09 M | 100.00% | 1.00% | |
| UBS GROUP AG | 05/05/2026 | 976.36 K | $15.13 M | 130.59% | 0.89% |
| AFFINITY ASSET ADVISORS, LLC | 05/14/2026 | 967.62 K | $15.00 M | 0.00% | 0.88% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 05/14/2026 | 938.16 K | $14.54 M | -23.06% | 0.85% |
| WOODLINE PARTNERS LP | 05/15/2026 | 925.44 K | $14.34 M | 0.00% | 0.84% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/15/2026 | 924.04 K | $14.32 M | -4.33% | 0.84% |
| CAPITAL WORLD INVESTORS | 05/13/2026 | 893.33 K | $13.85 M | 100.00% | 0.81% |
| NORTHERN TRUST CORP | 05/14/2026 | 854.47 K | $13.24 M | 6.06% | 0.78% |
| NUVEEN, LLC | 04/30/2026 | 812.60 K | $12.60 M | 3.59% | 0.74% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 802.15 K | $12.43 M | 8.91% | 0.73% |
| DIMENSIONAL FUND ADVISORS LP | 05/07/2026 | 780.70 K | $12.09 M | 81.14% | 0.71% |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 05/15/2026 | 700.00 K | $10.85 M | 133.33% | 0.64% |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 632.23 K | $9.80 M | 100.00% | 0.57% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 05/15/2026 | 620.82 K | $9.62 M | -15.55% | 0.56% |
| KENNEDY CAPITAL MANAGEMENT LLC | 05/13/2026 | 561.25 K | $8.70 M | 114.87% | 0.51% |
| HANDELSBANKEN FONDER AB | 04/28/2026 | 547.00 K | $8.48 M | 0.00% | 0.50% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2026 | 546.30 K | $8.47 M | 203.91% | 0.50% |
| CANDRIAM S.C.A. | 04/30/2026 | 534.26 K | $8.28 M | 0.00% | 0.49% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 05/15/2026 | 485.21 K | $7.52 M | 1,766.99% | 0.44% |
| CITIGROUP INC | 05/11/2026 | 477.41 K | $7.40 M | 179.02% | 0.43% |
| 05/15/2026 | 460.00 K | $7.13 M | 0.00% | 0.42% | |
| POINT72 ASSET MANAGEMENT, L.P. | 05/15/2026 | 449.11 K | $6.96 M | -86.02% | 0.41% |
| FISHER ASSET MANAGEMENT, LLC | 05/05/2026 | 384.83 K | $5.96 M | 100.00% | 0.35% |
Nurix Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 239 institutional investors and hedge funds held shares of Nurix Therapeutics Inc. The most heavily invested institutionals were:
BlackRock, Inc.: 8.93 M
Redmile Group, LLC: 7.73 M
Vestal Point Capital, LP: 6.5 M
Deep Track Capital, LP: 6.35 M
FMR LLC: 5.54 M
STATE STREET CORP: 5.14 M
106.32% of Nurix Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 132.46 M shares in the last 24 months. This purchase volume represents approximately $2.05 B in transactions.